---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-024714"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T00:29:45.024802+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# STRATA Skin Sciences Q1 revenue up 8.6% to $7.6M; net loss widens to $2.8M

## Summary
- Revenue of $7.6M vs $7.0M YoY; global recurring revenue $5.2M, equipment revenue $2.4M.
- Net loss of $2.8M ($0.08 loss per share) vs net loss of $2.5M ($0.07 per share) YoY.
- Launched TheraClear X in Jan 2023; placed 44 devices in Q1, total 58 U.S. placements.
- Sold over 3,000 TheraClear treatments in Q1; signed India distribution deal with Spectra Medical.
- Full-year 2023 revenue guidance reaffirmed at $38M–$40M.

## SEC filing metadata
- accession: 0001140361-23-024714
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036123024714/0001140361-23-024714-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036123024714/brhc20052965_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-024714
- JSON: https://secwatch.observer/filing/0001140361-23-024714.json
- Plain text: https://secwatch.observer/filing/0001140361-23-024714.txt

## Key facts
- Earnings Releases
  STRATA Skin Sciences, Inc. reported first quarter ended March 31, 2023 results: revenue $7.6 million, net income $2.8 million, EPS loss of $0.08 per basic and diluted common share. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2023
  - Revenue: $7.6 million
  - Net income: $2.8 million
  - EPS: loss of $0.08 per basic and diluted common share
  - Guidance: reaffirmed
  - Result: reported results
  source text: EXHIBIT 99.1 Exhibit 99.1 Press Release dated May 15, 2023 issued by STRATA Skin Sciences, Inc. STRATA Skin Sciences Reports First Quarter 2023 Revenue Achieved revenue of $7.6 million for the first quarter 2023 Company to host conference call and webcast today, May 15, 2023, at 4:30 PM ET HORSHAM, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000114036123024714/0001140361-23-024714-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.